2020
Association of SLC1A1 Gene Polymorphism With Obsessive Compulsive Disorder in a Sample From Southern India
Shukla T, Nadella R, J. R, Ganesh S, Nestadt G, Purushottam M, Jain S, Reddy Y, Viswanath B. Association of SLC1A1 Gene Polymorphism With Obsessive Compulsive Disorder in a Sample From Southern India. Experimental And Clinical Psychopharmacology 2020, 28: 617-621. PMID: 31985241, DOI: 10.1037/pha0000348.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderTreatment responseAge of onsetSRI treatment responseSignificant associationClinical parametersMini International Neuropsychiatric InterviewGenotype/allele frequenciesSymptom dimensionsSpecialty OCD clinicAdequate trialFull respondersNeuropsychiatric InterviewHealthy controlsBrain volumeGene polymorphismsOCD clinicDisease severityCase-control association analysisSymptom severityOCD patientsOCD casesGenotype frequenciesCompulsive disorderAssociation
2019
Pellagra and Alcohol Dependence Syndrome: Findings From a Tertiary Care Addiction Treatment Centre in India
Narasimha V, Ganesh S, Reddy S, Shukla L, Mukherjee D, Kandasamy A, Chand P, Benegal V, Murthy P. Pellagra and Alcohol Dependence Syndrome: Findings From a Tertiary Care Addiction Treatment Centre in India. Alcohol And Alcoholism 2019, 54: 148-151. PMID: 30721993, DOI: 10.1093/alcalc/agz004.Peer-Reviewed Original ResearchConceptsAlcohol dependence syndromeAddiction treatment centersInpatient careHigh doseTreatment centersDependence syndromeLife-threatening comorbiditiesAcute medical conditionsDeficiency of niacinMulti-systemic diseaseMinority of casesTwo-thirdsPeripheral neuropathyClinical presentationParenteral vitaminDelirium tremensMultivitamin supplementsClassical triadComplete resolutionAssociated conditionMedical conditionsPrompt identificationHigh indexAlcohol dependenceComplete recovery
2018
Six months' course and outcome of metabolic abnormalities in a cohort of patients with schizophrenia in rural India
Bijjal S, Ganesh S, Rawat V, Agarwal V, Reddy K, Devi N, Kumar C, Christopher R, Thirthalli J. Six months' course and outcome of metabolic abnormalities in a cohort of patients with schizophrenia in rural India. Schizophrenia Research 2018, 201: 415-416. PMID: 29880456, DOI: 10.1016/j.schres.2018.05.016.Peer-Reviewed Original Research
2017
BDNF gene and obsessive compulsive disorder risk, symptom dimensions and treatment response
J R, Ganesh S, Shukla T, Deolankar S, Nadella R, Sen S, Purushottam M, Reddy Y, Jain S, Viswanath B. BDNF gene and obsessive compulsive disorder risk, symptom dimensions and treatment response. Asian Journal Of Psychiatry 2017, 38: 65-69. PMID: 29079096, DOI: 10.1016/j.ajp.2017.10.014.Peer-Reviewed Original ResearchPrevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population
Rawat V, Ganesh S, Bijjal S, Reddy K, Agarwal V, Devi R, Kumar C, Christopher R, Thirthalli J. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population. Schizophrenia Research 2017, 192: 102-107. PMID: 28454923, DOI: 10.1016/j.schres.2017.04.039.Peer-Reviewed Original ResearchConceptsPredictors of MetSGeneral population controlsAntipsychotic exposureMetabolic syndromeOdds ratioFemale genderRural south Indian populationInternational Diabetes Federation criteriaDiagnosis of MetSSubgrouping of patientsPhysical activity patternsSouth Indian populationPopulation controlsFederation criteriaClinical parametersSouth IndiaTreatment detailsHealthy controlsIndependent riskLow prevalenceGeneral populationTreatment groupsPatientsSchizophrenia patientsControl group
2016
Prevalence and determinants of metabolic syndrome in patients with schizophrenia: A systematic review and meta-analysis of Indian studies
Ganesh S, Ashok A, Kumar C, Thirthalli J. Prevalence and determinants of metabolic syndrome in patients with schizophrenia: A systematic review and meta-analysis of Indian studies. Asian Journal Of Psychiatry 2016, 22: 86-92. PMID: 27520904, DOI: 10.1016/j.ajp.2016.05.006.Peer-Reviewed Original ResearchConceptsMetabolic syndromePooled prevalenceSchizophrenia patientsLow prevalenceSystematic reviewNCEP ATP III criteriaDeterminants of MetSDrug-naïve patientsCase-control designUnderstanding of prevalenceHospital studyHigh prevalenceHospital settingPrevalence ratesPatientsScience Direct databasesCommunity settingsSyndromePrevalenceLiterature searchIndian studiesHospitalSchizophreniaGoogle ScholarConflicting results